JPS6120278B2 - - Google Patents

Info

Publication number
JPS6120278B2
JPS6120278B2 JP9464478A JP9464478A JPS6120278B2 JP S6120278 B2 JPS6120278 B2 JP S6120278B2 JP 9464478 A JP9464478 A JP 9464478A JP 9464478 A JP9464478 A JP 9464478A JP S6120278 B2 JPS6120278 B2 JP S6120278B2
Authority
JP
Japan
Prior art keywords
substance
hydroxymethylphosphinoyl
amino
butyric acid
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP9464478A
Other languages
Japanese (ja)
Other versions
JPS5521754A (en
Inventor
Michio Kojima
Takashi Tsuruoka
Akira Suzuki
Shigeharu Inoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP9464478A priority Critical patent/JPS5521754A/en
Publication of JPS5521754A publication Critical patent/JPS5521754A/en
Publication of JPS6120278B2 publication Critical patent/JPS6120278B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は無公害抗黴剤および除草剤として有用
な抗生物質、SF−1293物質の培養による製造法
の改良に関するものである。 SF−1293物質は特公昭51−639号公報(特許第
827768号)記載の製造法によつてはじめて製造さ
れた抗生物質で、次式: の構造を有する。SF−1293物質は特公昭51−639
号公報に記載されるごとく広範な抗黴活性を有す
るほか、広範囲の植物に対して除草活性を示す除
草剤として特に有用な物質である〔特開昭54−
67026号、特公昭59−23282号公報(特許第
1270965号)〕。 従来、除草剤は有機合成による人工的合成化合
物が広く使用されており、これらは非天然物のた
め分解が遅く、環境汚染の一つの原因となる場合
があり得る。しかるにSF−1293物質は微生物に
より生産され、速やかに分解を受ける点で環境汚
染のない理想的な除草剤と考えられる。この理由
はSF−1293物質が光学活性的にL型体よりなる
天然物で、土壤細菌により容易に代謝され易い形
をしているためである。SF−1293物質を有機合
成的に製造する方法も知られているが(明菓年報
13巻、54頁、1973年)、合成収量が低く、しかも
得られるものは光学的に不活性なD体とL体の混
合物で、この中、非天然型のD体は土壤細菌によ
る分解が遅いという難点も考えられる。 一方、SF−1293物質の生合成過程を考察する
に、式: で表わされるヒドロキシメチルホスフイノイル基
を有する化合物が重要な役割を担つていることが
推定され、かゝるヒドロキシメチルホスフイノイ
ル基含有化合物をストレプトミセス属に属する
SF−1293物質生産菌の培養に際し添加したとこ
ろ、高率でSF−1293物質に変換されることを見
出して本発明を確立した。 したがつて本発明は、ストレプトミセス属に属
するSF−1293物質生産菌にSF−1293物質前駆体
としてL−2−アミノ−4−(ヒドロキシメチル
ホスフイノイル)酪酸、DL−2−アミノ−4−
(ヒドロキシメチルホスフイノイル)酪酸、メチ
ルホスフイン酸及びそれらの塩から選んだヒドロ
キシメチルホスフイノイル基含有物質を添加して
培養し、培養物からSF−1293物質を採取するこ
とを特徴とする抗生物質SF−1293物質の高収率
製造法を提供するものである。 本発明の方法においてヒドロキシメチルホスフ
イノイル基含有物質として使用される基本的化合
物の構造式は下記のとおりである。 2−アミノ−4−(ヒドロキシメチルホスフイ
ノイル)酪酸 メチルホスフイン酸 本発明の方法によれば、前記現象を利用して
SF−1293物質の生成収量を飛躍的に増大せしめ
得、製造コストの低減に寄与するのできわめて有
利である。 さらに本発明者らは、本発明の方法において
SF−1293物質前駆体としてL−2−アミノ−4
−(ヒドロキシメチルホスフイノイル)酪酸を使
用すれば低濃度ではほぼ100%の変換率でSF−
1293物質に変換されるに対し、合成により得られ
る該化合物のDL体はL体に比して約50%の変換
率であることを見出し、したがつて本発明の方法
をDL−2−アミノ−4−(ヒドロキシメチルホス
フイノイル)酪酸又はその塩の光学分割に応用し
得ることを認めた。かゝる光学分割は、具体的に
は、ストレプトミセス属に属するSF−1293物質
生産菌にSF−1293物質前駆体としてDL−2−ア
ミノ−4−(ヒドロキシメチルホスフイノイル)
酪酸又はその塩を添加培養してL−2−アミノ−
4−(ヒドロキシメチルホスフイノイル)酪酸又
はその塩を選択的に消費させ、培養液中に残留す
るD−2−アミノ−4−(ヒドロキシメチルホス
フイノイル)酪酸又はその塩をそれ自体既知の方
法で単離することによつて達成し得る。 本発明の培養法において使用される微生物はス
トレプトミセス属に属するSF−1293物質を生産
する任意の菌株であり、代表的な一菌株はストレ
プトミセス・ハイグロスコピクス SF−1293
(Streptomyces hygroscopicus SF−1293)と命
名され、工業技術院微生物工業技術研究所にスト
レプトミセス エスピー、SF−1293の表示で微
工研条寄第130号(FERM BP−130)(微工研菌
寄第996号より移管)として国際寄託された菌株
である。さらにSF−1293物質生産に関して2−
アミノ−4−(ヒドロキシメチルホスフイノイ
ル)酪酸依存性変異株等の種々の変異株を使用す
ることもできる。培地としては通常の微生物の醗
酵生産に使用される各種の栄養源が使用できる。
たとえば、炭素源としては澱粉、グルコース、グ
リセリン、大豆油等、窒素源としては大豆粉、小
麦胚芽、ポリペプトン、ソリユーブル・ベジタブ
ル・プロテイン等をあげることができる。 培養法は一般の抗生物質の生産及び変換と同じ
く、液体培養法、特に深部培養法が最も適してい
る。培養及び変換は好気的に行なわれ、培養に適
当な温度は20〜37℃であるが、多くの場合は28℃
附近で行われる。培養、変換は振盪、タンク培養
共に通常2〜5日で最高力価に達する。培養法自
体の詳細については前記特公昭51−639号公報の
記載を参照されたい。 SF−1293物質の検定は枯草菌の変異株No.8193
株を使用する微生物検定法による。すなわち、グ
ルコース1.0%、ミート・エキストラクト0.5%、
NH4H2PO40.1%、NaCl 0.5%、MgSO4
7H2O0.02%、K2HPO40.3%、寒天1.5%(PH7.0)
の培地に胞子懸濁液を植菌し、寒天平板を作成
し、ペーパーデイスク法により検定する。 SF−1293物質は3〜50μg/mlの範囲内で濃度
の対数値と阻止直径との間で直線関係を示す。 本発明の特徴とする添加培養にDL−2−アミ
ノ−4−(ヒドロキシメチルホスフイノイル)酪
酸を使用した場合、培養液中には生成するSF−
1293物質と、利用されずに残存しているD−2−
アミノ−4−(ヒドロキシメチルホスフイノイ
ル)酪酸とが共存するが、両者の分離には特にイ
オン交換樹脂によるクロマトグラフイーが有効で
ある。たとえば、培養物をアンバーライトIRA−
400またはダウエツクス1×2(酢酸型)の充填
塔にかけ、酢酸溶液で溶離展開すると、D−2−
アミノ−4−(ヒドロキシメチルホスフイノイ
ル)酪酸はSF−1293物質の後に溶出され、両物
質をそれぞれ純粋に単離することが可能である。 回収されたD−2−アミノ−4−(ヒドロキシ
メチルホスフイノイル)酪酸は水又は稀アルカリ
水溶液に溶解し、密閉容器中で温度150〜250℃に
加熱する等のラセミ化の手段で容易にDL体に変
換でき、再度添加培養に利用することができる。
特に本発明においては、培養及び分画とラセミ化
法とを組合せることによつて、2−アミノ−4−
(ヒドロキシメチルホスフイノイル)酪酸のDL体
を高い利用効率でSF−1293物質へ転換できる利
点がある。 つぎに本発明を実施例によつて説明する。 実施例 1 ストレプトミセス・ハイグロスコピクス SF
−1293株(微工研条寄第130号)の胞子を可溶性
澱粉2.0%、ポリペプトン1.0%、ミート・エキス
トラクト0.3%、K2HPO40.05%(PH6.0〜7.0)か
らなる培地に植菌し、28℃で24時間振盪培養す
る。この種培養を2%の割合で、グリセリン2.75
%、小麦胚芽3.26%、サングレイン0.5%、大豆
油0.2%、CoCl2・6H2O0.001%、NiCl2
6H2O0.0001%、NaH2PO40.005%及び第1表に示
す濃度で前駆体を添加した培地に植菌し、28℃で
96時間振盪培養する。培養液を遠心分離
(3000rpm、15分)して上澄を得、これを稀釈し
て検定を行なつた。その結果を第1表に示す。
The present invention relates to an improved method for producing SF-1293, an antibiotic useful as a non-polluting antifungal agent and herbicide, by culturing. SF-1293 substance is disclosed in Japanese Patent Publication No. 51-639 (Patent No.
It is an antibiotic produced for the first time by the production method described in No. 827768), and has the following formula: It has the structure of SF-1293 substance is Special Publication No. 51-639
As described in the publication, in addition to having a wide range of antifungal activity, it is a particularly useful substance as a herbicide that exhibits herbicidal activity against a wide range of plants.
67026, Special Publication No. 59-23282 (Patent No.
1270965)]. Conventionally, herbicides have been widely used as artificially synthesized compounds based on organic synthesis, and since these are non-natural products, they decompose slowly and may become a cause of environmental pollution. However, the SF-1293 substance is produced by microorganisms and is rapidly decomposed, so it is considered an ideal herbicide that does not pollute the environment. The reason for this is that the SF-1293 substance is a natural product that is optically active in the L form, and is in a form that is easily metabolized by soil bacteria. A method for producing SF-1293 substance by organic synthesis is also known (Meika Annual Report
(Vol. 13, p. 54, 1973), the synthesis yield is low, and what is obtained is a mixture of optically inactive D and L isomers, of which the non-natural D isomer cannot be degraded by soil bacteria. There may also be a drawback that it is slow. On the other hand, considering the biosynthesis process of SF-1293 substance, the formula: It is presumed that compounds having a hydroxymethylphosphinoyl group represented by
The present invention was established by discovering that when added to the culture of SF-1293 substance-producing bacteria, it was converted to SF-1293 substance at a high rate. Therefore, the present invention provides L-2-amino-4-(hydroxymethylphosphinoyl)butyric acid and DL-2-amino-4 as SF-1293 substance precursors to SF-1293 substance-producing bacteria belonging to the genus Streptomyces. −
(Hydroxymethylphosphinoyl) A hydroxymethylphosphinoyl group-containing substance selected from butyric acid, methylphosphinic acid, and their salts is added to culture, and SF-1293 substance is collected from the culture. The present invention provides a high-yield production method for antibiotic SF-1293 substance. The structural formula of the basic compound used as the hydroxymethylphosphinoyl group-containing substance in the method of the present invention is as follows. 2-amino-4-(hydroxymethylphosphinoyl)butyric acid Methylphosphinic acid According to the method of the present invention, utilizing the above phenomenon,
This is extremely advantageous because it can dramatically increase the production yield of SF-1293 substance and contribute to reducing manufacturing costs. Furthermore, in the method of the present invention, the present inventors
L-2-amino-4 as SF-1293 substance precursor
-(Hydroxymethylphosphinoyl)butyric acid allows SF- with almost 100% conversion at low concentrations.
1293 substance, the DL form of the compound obtained by synthesis has a conversion rate of about 50% compared to the L form. It was found that the present invention can be applied to the optical resolution of -4-(hydroxymethylphosphinoyl)butyric acid or its salt. Specifically, such optical resolution is performed by injecting DL-2-amino-4-(hydroxymethylphosphinoyl) into SF-1293 substance-producing bacteria belonging to the genus Streptomyces as an SF-1293 substance precursor.
L-2-amino-
4-(Hydroxymethylphosphinoyl)butyric acid or its salt is selectively consumed, and D-2-amino-4-(hydroxymethylphosphinoyl)butyric acid or its salt remaining in the culture solution is removed by a method known per se. This can be achieved by isolation by method. The microorganism used in the culture method of the present invention is any strain that produces the SF-1293 substance belonging to the genus Streptomyces, and one representative strain is Streptomyces hygroscopicus SF-1293.
(Streptomyces hygroscopicus SF-1293), and was designated as Streptomyces sp. This is a strain internationally deposited as (transferred from No. 996). Furthermore, regarding the production of SF-1293 substance 2-
Various mutant strains can also be used, such as amino-4-(hydroxymethylphosphinoyl)butyric acid dependent mutants. As the medium, various nutrient sources commonly used in microbial fermentation production can be used.
For example, carbon sources include starch, glucose, glycerin, soybean oil, etc., and nitrogen sources include soybean flour, wheat germ, polypeptone, soluble vegetable protein, etc. As with general antibiotic production and conversion, the most suitable culture method is liquid culture, especially deep culture. Cultivation and conversion are carried out aerobically, with suitable culturing temperatures ranging from 20 to 37°C, but often 28°C.
It will be held nearby. Culture and conversion usually reach the maximum titer in 2 to 5 days for both shaking and tank culture. For details of the culture method itself, please refer to the above-mentioned Japanese Patent Publication No. 51-639. SF-1293 substance assay is Bacillus subtilis mutant strain No.8193
By microbial assay using strains. i.e. glucose 1.0%, meat extract 0.5%,
NH4H2PO4 0.1 %, NaCl 0.5%, MgSO4 .
7H2O0.02 %, K2HPO4 0.3 %, agar 1.5% (PH7.0)
Inoculate the spore suspension into a medium, prepare an agar plate, and assay using the paper disc method. The SF-1293 substance exhibits a linear relationship between logarithm of concentration and inhibition diameter within the range 3-50 μg/ml. When DL-2-amino-4-(hydroxymethylphosphinoyl)butyric acid is used in the additive culture, which is a feature of the present invention, SF-
1293 substance and remaining unused D-2-
Although amino-4-(hydroxymethylphosphinoyl)butyric acid coexists, chromatography using an ion exchange resin is particularly effective for separating the two. For example, culture Amberlite IRA−
D-2-
Amino-4-(hydroxymethylphosphinoyl)butyric acid eluted after the SF-1293 substance, allowing both substances to be isolated in their respective pure forms. The recovered D-2-amino-4-(hydroxymethylphosphinoyl)butyric acid can be easily racemized by dissolving it in water or a dilute alkaline aqueous solution and heating it to a temperature of 150 to 250°C in a closed container. It can be converted into DL form and used again for supplementation culture.
In particular, in the present invention, 2-amino-4-
It has the advantage that the DL form of (hydroxymethylphosphinoyl)butyric acid can be converted to SF-1293 substance with high utilization efficiency. Next, the present invention will be explained with reference to examples. Example 1 Streptomyces hygroscopicus SF
-1293 strain (Feikoken Joyori No. 130) was inoculated into a medium consisting of 2.0% soluble starch, 1.0% polypeptone, 0.3% meat extract, and 0.05% K 2 HPO 4 (PH 6.0 to 7.0). Incubate the cells with shaking at 28°C for 24 hours. Glycerin 2.75
%, wheat germ 3.26%, sungrain 0.5%, soybean oil 0.2%, CoCl2.6H2O0.001 % , NiCl2 .
6H 2 O 0.0001%, NaH 2 PO 4 0.005%, and a medium supplemented with precursors at the concentrations shown in Table 1 were inoculated and incubated at 28°C.
Incubate with shaking for 96 hours. The culture solution was centrifuged (3000 rpm, 15 minutes) to obtain a supernatant, which was diluted and assayed. The results are shown in Table 1.

【表】 第1表に示すように前駆体の添加効果は明らか
である。 実施例 2 実施例1と同じ前培養条件で培養を行ない、生
産培地中に200μg/mlのDL−2−アミノ−4−
(ヒドロキシメチルホスフイノイル)酪酸を添加
し、96時間振盪培養する。得られた培養液のPHを
2.0に調整し、遠心分離により菌体を除去し、1.2
の培養液を得た。培養力価は600μg/mlであ
つた。50mlの活性炭カラムに通じ脱色後、500ml
のダウエツクス50W(H+タイプ)に吸着せし
め、500mlの水で洗滌する。溶離は0.05Nの
NH4OHで行ない、抗菌性を示す画分を集めて濃
縮乾固すると約2.3gの粗粉末が得られ、この粉
末のSF−1293物質の比活性は285μg/mgであつ
た。つぎに、この粗粉末を約10mlの水に溶解し、
100ml容のダウエツクス(CH3COO-型)に吸
着せしめ、水でカラムを洗滌した。0.2N酢酸に
て溶離すると、SF−1293物質を含む画分940mgが
得られた。SF−1293物質の比活性は600μg/mg
であつた。D−2−アミノ−4−(ヒドロキシメ
チルホスフイノイル)酪酸の分離はカラムを引続
いて0.5N酢酸にて溶離、ニンヒドリン反応陽性
画分を集め、濃縮乾固することによつて行ない、
150mgの粗粉末を得た。この粉末を0.5mlの水に溶
解し、PH5.5に調整した後、50ml容のダウエツク
ス1×2(CH3COO-型)200〜400メツシユに吸
着せしめ、水及び0.2N酢酸でカラムを洗滌する
と、0.2N酢酸にてSF−1293物質が23mg回収され
た。つぎにカラムを0.5N酢酸にて溶離し、ニン
ヒドリン反応陽性画分を集めて濃縮乾固すると92
mgのD−2−アミノ−4−(ヒドロキシメチルホ
スフイノイル)酪酸の結晶が得られた。 この結晶の性質は、融点152℃、旋光度〔α〕D
=−26.2゜(c=1.0、1N HCl)であり、 元素分析値は分子式C5H12NO4Pより求めた 計算値 C33.16% H6.68% N7.73% に対し、 測定値 C32.87% H6.71% N7.45% であつた。 このD−2−アミノ−4−(ヒドロキシメチル
ホスフイノイル)酪酸50mgを水0.2mlに溶解し、
封管中150℃で25時間加熱し、得られる反応液を
炭末で脱色後、乾固し、水−エタノールから再結
晶化してDL−2−アミノ−4−(ヒドロキシメチ
ルホスフイノイル)酪酸の結晶42mgを得た。
[Table] As shown in Table 1, the effect of adding the precursor is clear. Example 2 Culture was carried out under the same preculture conditions as in Example 1, and 200 μg/ml of DL-2-amino-4-
Add (hydroxymethylphosphinoyl)butyric acid and incubate with shaking for 96 hours. The pH of the obtained culture solution
Adjust to 2.0, remove bacterial cells by centrifugation, and 1.2
A culture solution was obtained. The culture titer was 600 μg/ml. After decolorizing through a 50ml activated carbon column, 500ml
Adsorb it on Dowex 50W (H + type) and wash it with 500ml of water. Elution is 0.05N
The antibacterial fractions were collected and concentrated to dryness to obtain about 2.3 g of crude powder, which had a specific activity of SF-1293 substance of 285 μg /mg. Next, dissolve this coarse powder in about 10ml of water,
The column was adsorbed onto 100 ml of Dowex (CH 3 COO - type) and the column was washed with water. Elution with 0.2N acetic acid yielded 940 mg of a fraction containing SF-1293 substance. The specific activity of SF-1293 substance is 600μg/mg
It was hot. D-2-amino-4-(hydroxymethylphosphinoyl)butyric acid was separated by successively eluting the column with 0.5N acetic acid, collecting the ninhydrin-positive fractions, and concentrating to dryness.
150 mg of coarse powder was obtained. This powder was dissolved in 0.5 ml of water and adjusted to pH 5.5, then adsorbed onto a 50 ml Dowex 1×2 (CH 3 COO - type) 200-400 mesh, and the column was washed with water and 0.2 N acetic acid. Then, 23 mg of SF-1293 substance was recovered with 0.2N acetic acid. Next, the column was eluted with 0.5N acetic acid, and the fractions positive for ninhydrin reaction were collected and concentrated to dryness.92
mg of D-2-amino-4-(hydroxymethylphosphinoyl)butyric acid crystals were obtained. The properties of this crystal are: melting point 152℃, optical rotation [α] D
= -26.2° (c = 1.0, 1N HCl), and the elemental analysis value was calculated from the molecular formula C 5 H 12 NO 4 P. The measured value was C32, compared to the calculated value of C33.16% H6.68% N7.73%. .87% H6.71% N7.45%. Dissolve 50 mg of this D-2-amino-4-(hydroxymethylphosphinoyl)butyric acid in 0.2 ml of water,
Heated in a sealed tube at 150°C for 25 hours, decolorized the resulting reaction solution with charcoal powder, dried it, and recrystallized from water-ethanol to obtain DL-2-amino-4-(hydroxymethylphosphinoyl)butyric acid. 42 mg of crystals were obtained.

Claims (1)

【特許請求の範囲】[Claims] 1 ストレプトミセス属に属するSF−1293物質
生産菌にSF−1293物質前駆体としてL−2−ア
ミノ−4−(ヒドロキシメチルホスフイノイル)
酪酸、(−DL−2−アミノ−4−(ヒドロキシメチ
ルホスフイノイル)酪酸、)−メチルホスフイン酸
及びそれらの塩から選んだヒドロキシメチルホス
フイノイル基含有物質を添加して培養し、培養物
からSF−1293物質を採取することを特徴とする
抗生物質SF−1293物質の高収率製造法。
1 L-2-amino-4-(hydroxymethylphosphinoyl) was used as an SF-1293 substance precursor in SF-1293 substance-producing bacteria belonging to the genus Streptomyces.
A substance containing a hydroxymethylphosphinoyl group selected from butyric acid, (-DL-2-amino-4-(hydroxymethylphosphinoyl)butyric acid,)-methylphosphinic acid and salts thereof is added and cultured. A method for producing an antibiotic SF-1293 substance with high yield, which comprises collecting the SF-1293 substance from a substance.
JP9464478A 1978-08-04 1978-08-04 Production in high yield of antibiotic sf-1293 Granted JPS5521754A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9464478A JPS5521754A (en) 1978-08-04 1978-08-04 Production in high yield of antibiotic sf-1293

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9464478A JPS5521754A (en) 1978-08-04 1978-08-04 Production in high yield of antibiotic sf-1293

Publications (2)

Publication Number Publication Date
JPS5521754A JPS5521754A (en) 1980-02-16
JPS6120278B2 true JPS6120278B2 (en) 1986-05-21

Family

ID=14115963

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9464478A Granted JPS5521754A (en) 1978-08-04 1978-08-04 Production in high yield of antibiotic sf-1293

Country Status (1)

Country Link
JP (1) JPS5521754A (en)

Also Published As

Publication number Publication date
JPS5521754A (en) 1980-02-16

Similar Documents

Publication Publication Date Title
EP0133033B1 (en) Process for producing optically active aryloxypropionic acids and derivatives thereof
US3239394A (en) Process for producing 7-amino-cephalosporanic acid
EP0186035B1 (en) D-amino acid transaminase and its use
CA1196591A (en) Process for producing ribavirin
EP0044477B1 (en) Process for production of antibiotics, and novel antibiotics produced thereby
US4764606A (en) 7-formylaminocephalosporin compounds
JPS59113896A (en) Preparation of pyrroloquinolinequinone
US5169767A (en) Method of producing trehalose
JPS6120278B2 (en)
US5441888A (en) Process for producing D-mandelic acid from benzoylformic acid
EP0784697B1 (en) Bacterial process for the resolution of racemic cis-diols
JPS61247396A (en) Production of genisteine
JPH0226957B2 (en)
JPH022589B2 (en)
JPS58201992A (en) Preparation of beta-substituted propionic acid or amide thereof by microorganism
US4723004A (en) Cephem compounds
US4296040A (en) Antibiotic nanaomycin E and a process for producing the same
US4296107A (en) Mildiomycin analogs and a method of production
JP3030916B2 (en) Method for producing β-glucooligosaccharide
JPS6170994A (en) Production of cyclic(1-2)-beta-d-glucan
JPS6350991B2 (en)
JPH01181797A (en) Production of d-threo-3-(3,4-dihydroxyphenyl)serine derivative
JPH0638744B2 (en) New microorganism
JPS5928481A (en) Antibiotic substance y-02039h and preparation thereof
JPS6338038B2 (en)